Precursor B-cell lymphoblastic lymphoma presenting as an orbital mass

Orbit

Volumn 18, Issue 1, 1999, Pages 17-24

  Alford, Mark A ^a   Nerad, Jeffrey A ^a   Conlan, M Ronan ^b   Comito, Melanie ^c   Giller, Roger H ^d  

^a UNIVERSITY OF IOWA HOSPITALS AND CLINICS   (United States)

^b Saskatoon City Hospital   (Canada)

^c UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF SOUTH DAKOTA   (United States)

Author keywords

Children; Lymphoblastic lymphoma; Non Hodgkin's lymphoma; Orbital tumor

Indexed keywords

ANTINEOPLASTIC AGENT; ASPARAGINASE; CARMUSTINE; CYCLOPHOSPHAMIDE; CYTARABINE; HYDROXYUREA; TIOGUANINE;

ARTICLE; B CELL LYMPHOMA; CANCER DIAGNOSIS; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; EXOPHTHALMOS; HISTOPATHOLOGY; HUMAN; INTRATHECAL DRUG ADMINISTRATION; LYMPHOBLASTOMA; MALE; NONHODGKIN LYMPHOMA; ORBIT TUMOR; SCHOOL CHILD; STEM CELL; TUMOR BIOPSY;

EID: 0033059876     PISSN: 01676830     EISSN: None     Source Type: Journal    
DOI: 10.1076/orbi.18.1.17.2723     Document Type: Article

References (27)

1. 2). N Engl J Med 1983;308:559-65.
2. 2 Shields JA, Bakewell B, Augsburger JJ, Donoso LA, Bernardino V. Classification and incidence of space-occupying lesions of the orbit. Arch Ophthalmol 1984;102:1606-11.
3. 3 Henderson J. Orbital Tumors. New York: Raven Press, 1994.
4. 4 Shields JA, Bakewell B, Augsburger JJ, Donoso LA, Bernardino V. Space-occupying orbital masses in children. A review of 250 consecutive biopsies. Ophthalmology 1986;93:379-84.
5. 5 Bullock JD, Goldberg SH, Rakes SM. Orbital tumors in children. Ophthalm Plast Reconstr Surg 1989;5:13-6.
6. 6 Jakobiec FA, Neri A, Knowles DM. Genotypic monoclonality in immunophenotypically polyclonal orbital lymphoid tumors: A model of tumor progression in the lymphoid system. Ophthalmology 1987;94:980-94.
7. 7 Jacobiec FA, Iwamoto T, Knowles, DM. Ocular adnexal lymphoid tumors: correlative ultrastructural and immunologic marker studies. Arch Ophthalmol 1982;100:84-90.
8. 8 Knowles DM, Jacobiec FA. Orbital lymphoid neoplasms. A clinicopathological study of 60 patients. Cancer 1980;46:576-89.
9. 9 Ellis JM, Banks PM, Campbell RJ, et al. Lymphoid tumors of the ocular adnexa: clinical correlation with the working formulation classification and immunoperoxidase staining of paraffin sections. Ophthalmology 1985;92:1311-24.
10. 10 McNally L, Jacobiec FA, Knowles DM. Clinical, morphological, immunophenotypic, and molecular genetic analysis of bilateral ocular adnexal lymphoid neoplasms in 17 patients. Am J Ophthalmol 1987;103:555-68.
11. 11 Van der Gaag R, Koornneef L, Van Heerde P, et al. Lymphoid proliferations in the orbit: malignant or benign? Br J Ophthalmol 1984;68:892-900.
12. 12 Magrath IT. Malignant non Hodgkin's lymphomas. In: Pizzo PA, Poplack DG, eds. Principles and practice of pediatric oncology. Philadelphia, PA: Lippincott, 1996: 545-8.
13. 13 Griffith RC, Kelly DR, Nathwani BN, et al. A morphologic study of childhood lymphoma of the lymphoblastic type: the Pediatric Oncology Group experience. Cancer 1989;59:1126-31.
14. 14 Murphy SB, Fairclough DL, Hutchinson RE, et al. Non-Hodgkin's lymphoma of childhood: an analysis of the histology, staging, and response to treatment of 338 cases at a single institution. J Clin Oncol 1989;7:186-93.
15. 15 Kaplinsky C, Zaizov R. Childhood B-cell non-Hodgkin's lymphoma in Israel. Leukemia Lymphoma 1994; 1:49-53.
16. 16 Knowles DM, Jakobiec FA. Ocular adnexal lymphoid neoplasms: clinical, histopathologic, electron microscopic, and immunologic characteristics. Hum Pathol 1982;13:148-62.
17. 17 Kamps WA, Poppema S. Pre-B-cell non-Hodgkin's lymphoma in childhood. Am J Clin Pathol
18. 18 Link MP, Roper M, Dorfman RF, Crist WM, Cooper MD, Levy R. Cutaneous lymphoblastic lymphoma with pre-B-cell markers. Blood 1983;61:838-41.
19. 19 Smith RG. Parosteal lymphoblastic lymphoma. Cancer 1984;54:471-6.
20. 20 Donlon JA, Jaffe ES, Braylan RC. Terminal deoxynucleotidyl transferase activity in malignant lymphomas. New Engl J Med 1977;297:461-4.
21. 21 Chessels J, Hardisty RM, Rapson NT, et al. Acute lymphoblastic leukemia in children: classification and prognosis. Lancet 1982;2:1307-9.
22. 22 Wollner N, Burchenal JH, Leiberman PH, et al. Non-Hodgkin's lymphoma in children: a comparative study of two modalities of therapy. Cancer 1976;37:123-34.
23. 23 Hvizdala EV, Berard C, Callihan T, et al. Lymphoblastic lymphoma in children: a randomized trial comparing LSA2-L2 with the ACOP+ therapeutic regimen. A Pediatric Oncology Group study. J Clin Oncol 1988;6:26-33.
24. 24 Sullivan MP, Boyett J, Pullen J, et al. Pediatric Oncology Group experience with modified LSA2-L2 therapy in 107 children with non-Hodgkin's lymphoma (Burkitt's lymphoma excluded). Cancer 1985;55:323-36.
25. 25 Meadows AT, Sposto R, Jenkins RDT, et al. Similar efficacy of 6 and 18 months of therapy with four drugs (COMP) for localized non-Hodgkin's lymphoma of children: a report from the Children's Cancer Study Group. J Clin Oncol 1989;7:92-9.
26. 26 Murphy SB, Hustu HO, Rivera G et al. End results of treating children with localized non-Hodgkin's lymphoma with a combined modality approach of lessened intensity. J Clin Oncol 1983;1:326-30.
27. 27 Magrath IT. Malignant non-Hodgkin's lymphoma in children. Hemat Oncol Clin N Am 1987;1:577-602.